drugset / Trial / NCT06319625

Effectiveness of Stellate Ganglion Block in Patients Diagnosed With Parkinson's Disease

NCT06319625 ↗

Unknown 80 enrolled Copka Sonpashan
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this or clinical trial is to explore efficacy of stellate ganglion block on dysphagia and activities of daily living in patients with Parkinson's disease. The main question it aims to answer are: • Can stellate ganglion block improve the dysphagia and activities of daily living in patients with Parkinson's disease. Participants will be divided into the the control group and observation group evenly. All the patients were provided with routine therapy, while the patients in the observation group were given stellate ganglion block. The swallowing function, and activities of daily living of the two groups of patients before and after treatment were evaluated.

Timeline

Start
2024-03
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 ml Other

Indications